Hereditary C6 deficiency in man
- PMID: 807274
Hereditary C6 deficiency in man
Abstract
An 18-year-old black female (D.B.) in good general health was found to have no hemolytic activity in serum CH50 titrations. Functional assays yielded normal values for all C components except C6. C6 was not detectable in plasma or serum by two different functional assays nor by antigenic analysis using monospecific anti-C6 antibody. Hemolytic activity was restored by addition of functionally pure C6. By specific functional assay, both parents and 5 of 6 available sibs had approximately half-normal serum C6 levels and 1 sib was normal. Biologic properties of D.B. serum include: a) absent bactericidal activity against S. typhi 0 901 with or without added rabbit antibody; b) normal generation of chemotactic activity for human neutrophils in the presence of endotoxin or aggregated IgG; c) ability to sensitize appropriate cells for immune adherence of agglutination by anti-C3 Coombs serum; and d) inability to lyse PNH red cells in either acid hemolysis or "sugar water" tests. An extensive clotting workup by standard methods was within normal limits. These studies document for the first time a human kindred with C6 deficiency. This defect exhibits a classic mendelian autosomal inheritance, with all 3 genotypes being recognizable. Unlike the C6-deficient rabbits studied by others, the homozygous C6-deficient human exhibits chemotactic and coagulation functions within the range of normal.
Similar articles
-
Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.J Clin Invest. 1974 Feb;53(2):544-53. doi: 10.1172/JCI107588. J Clin Invest. 1974. PMID: 11344568 Free PMC article.
-
Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.J Clin Invest. 1976 Jun;57(6):1635-43. doi: 10.1172/JCI108434. J Clin Invest. 1976. PMID: 777027 Free PMC article.
-
Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.J Clin Invest. 1976 Jun;57(6):1626-34. doi: 10.1172/JCI108433. J Clin Invest. 1976. PMID: 932197 Free PMC article.
-
Complement in clinical medicine.Dis Mon. 1975 Jan:1-54. Dis Mon. 1975. PMID: 46195 Review. No abstract available.
-
Significance of complement to the mechanism of action of endotoxin.Curr Top Microbiol Immunol. 1969;50:37-77. doi: 10.1007/978-3-642-46169-9_2. Curr Top Microbiol Immunol. 1969. PMID: 4907133 Review. No abstract available.
Cited by
-
Immunologic defense in bacterial and viral meningitis in children.Eur J Pediatr. 1976 Dec 9;124(1):1-12. doi: 10.1007/BF00452408. Eur J Pediatr. 1976. PMID: 1001323
-
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.Clin Exp Immunol. 2019 Apr;196(1):97-110. doi: 10.1111/cei.13240. Epub 2018 Dec 19. Clin Exp Immunol. 2019. PMID: 30444525 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous